首页> 外文期刊>The International journal of drug policy >Assessing the 'added value' of European policy on new psychoactive substances
【24h】

Assessing the 'added value' of European policy on new psychoactive substances

机译:评估欧洲政策对新精神物质的“附加值”

获取原文
获取原文并翻译 | 示例
           

摘要

Background: New psychoactive substances (NPS) are reported to be on the rise throughout Europe, and are often presented as the latest challenge facing drug -policy makers. At the European level, legislation on NPS has existed since 1998. Several evaluations, however, have suggested that this legislation is not effective and the European Commission has submitted a new proposal on NPS seeking to extend its powers in this area.
机译:背景:据报道,新的精神活性物质(NPS)遍布欧洲的崛起,通常呈现为药物 - 助理制造商面临的最新挑战。 在欧洲一级,自1998年以来就立法已经存在。然而,若干评估表明,这项立法并非有效,欧洲委员会已提交了关于在该领域延长其权力的NPS的新提案。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号